HALO-TRIAL: High, Medium And LOw Intensity Psychotherapy for Binge Eating Disorder
Key facts
- Where
- Ballerup Municipality, DenmarkSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT07698132, who can take part
Where in Denmark
- Mental Health Centre BallerupBallerup Municipality, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Herlev and Gentofte Hospital
- Trial code
- NCT07698132
- Record updated
- 13 July 2026
- Original description
The HALO trial is designed as a four-armed, assessor-blinded, fidelity-monitored randomized clinical trial. The goal of this randomized controlled study is to investigate the effectiveness of four different psychotherapy programs and to determine which one is most effective in reducing the number of binge-eating episodes in people with the eating disorder Binge Eating Disorder (BED), by directly comparing three intensities of Cognitive Behavioral Therapy-Enhanced against a manualized treatment as usual.Read full original descriptionShow less
The HALO trial is designed as a four-armed, assessor-blinded, fidelity-monitored randomized clinical trial. The goal of this randomized controlled study is to investigate the effectiveness of four different psychotherapy programs and to determine which one is most effective in reducing the number of binge-eating episodes in people with the eating disorder Binge Eating Disorder (BED), by directly comparing three intensities of Cognitive Behavioral Therapy-Enhanced against a manualized treatment as usual.
Participants will be asked to complete a 21-weeks randomized intervention and participate in follow up assesments.
Inclusion: Binge Eating Disorder according to DSM-5 criteria; 18-65 years of age; Fluent Danish speaker.
Exclusion: Concurrent psychotherapeutic treatment; Use of weight loss medications within the last month (i.e., GLP-1 receptor antagonists); Psychosis or psychotic disorders; Mania or bipolar disorder; Drug misuse disorder; Alcohol misuse disorder; Cluster B personality disorders in the severe range (diagnosed); Suicidal ideation or suicidality; Dosage of Antidepressants, Antipsychotics and Stimulants must be stable for at least 6 months.